(Q35036195)

5 August 2017

1 reference

title

Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies (English)

1 reference

idiopathic inflammatory myopathy

5 August 2017

1 reference

Ira N Targoff

1

1 reference

5 August 2017

1 November 2002

1 reference

Rheumatic Diseases Clinics of North America

5 August 2017

1 reference

5 August 2017

28

1 reference

5 August 2017

859-90, viii

1 reference

5 August 2017

4

1 reference

Steroid myopathy in connective tissue disease

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Creatine kinase activity inhibitor in sera from patients with muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The creatine-creatine phosphate energy shuttle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Racial differences in serum creatine kinase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Racial variation in serum creatine kinase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Reduced activity of serum creatine kinase in rheumatoid arthritis: a phenomenon linked to the inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical Significance of Low Creatine Phosphokinase Values in Patients With Connective Tissue Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Dermatomyositis without creatine kinase elevation. A poor prognostic sign

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Chronic pneumomediastinum and subcutaneous emphysema: association with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Adult idiopathic polymyositis without elevation of creatine kinase. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Fatal pneumomediastinum in dermatomyositis without creatine kinase elevation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical features of polymyositis/dermatomyositis with steroid-resistant interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Inclusion body myositis: clinical and pathological boundaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Assessment of inflammatory myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Investigation of serum creatine kinase variability after muscle-damaging exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Elevated serum creatine kinase level in diabetic patients with nephrotic syndrome: a role of fluid retention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Creatine Kinase MB Isoenzyme in Dermatomyositis: A Noncardiac Source

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Macro-CK disclosing disseminated epidermoid carcinoma of the pyriform sinus in a patient with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Laboratory manifestations of polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Serum Enzyme Alterations in Neuromuscular Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Misinterpretation of serum transaminase elevation in "occult" myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Serum carbonic anhydrase III in neuromuscular disorders and in healthy persons after a long-distance run.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Serum skeletal troponin I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Multiplicity of antibodies in myositis sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Distinctive features of idiopathic inflammatory myopathies in French Canadians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The association between Mi-2 antibodies and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Coexistence of two antisynthetases in a patient with the antisynthetase syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Autoantibody profiles in the sera of European patients with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Presence of the anti-Jo-1 autoantibody excludes inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Human isoleucyl-tRNA synthetase: sequence of the cDNA, alternative mRNA splicing, and the characteristics of an unusually long C-terminal extension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Polymyositis-associated overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Adult respiratory distress syndrome in polymyositis patients with the anti-Jo-1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Polymyositis-dermatomyositis-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

[A case of polymyositis with anti-Jo-1 antibody preceded by BOOP]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

[Acute polyarthritis, pulmonary fibrosis and Raynaud's phenomenon disclosing polymyositis with anti-JO-1 antibody associated with Gougerot-Sjögren syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Clinical and histological features of 'mechanic's hands' in a patient with antibodies to Jo-1--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Detection of anti-PL-12 autoantibodies by ELISA using a recombinant antigen; study of the immunoreactive region

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Myositis-specific autoantibodies: overview and recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Antibody to signal recognition particle in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Tacrolimus in refractory polymyositis with interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Analysis of the Mi-2 autoantigen of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Identification of a human 17p-located cDNA encoding a protein of the Snf2-like helicase family

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Characterization of the CHD family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Less specific myositis autoantibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Analysis of the specificity of anti-PM-Scl autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S rRNA 3' end formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Metabolic and mitochondrial myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900032-7

7 January 2021

10.1016/S0889-857X(02)00032-7

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12506776